[Action of 6870 RP (E 39) in malignant reticulonathies].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D012509:Sarcoma
D000970:Antineoplastic Agents
CYTOTOXIC DRUGS/therapeutic use; HODGKIN'S DISEASE/therapy; SARCOMA, RETICULUM CELL/therapy
Action du 6870 RP (E 39) dans les réticulopathies malignes.